Talk:Small cell lung cancer

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search

CASPIAN study

Hi, could you please add Caspian study? https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)32222-6/fulltext#seccestitle10

DO you think durvalumab will become more attractive ICP over atezolizumab due to more liberal scheduling q4 weeks?

This has been added. Hard to know which will become more attractive - probably a good case for a network meta-analysis to try to estimate which is the more effective and the less toxic! Jeremy L. Warner MD, MS (talk) 20:11, 2 November 2019 (EDT)

Retrieved from "https://hemonc.org/w/index.php?title=Talk:Small_cell_lung_cancer&oldid=40805"